“We don’t chase trends. Every technology we consider must meet rigorous standards: peer-reviewed research supporting efficacy, safety profiles appropriate for paediatric populations, and clear integration pathways with our existing ABA programs.”
Our medical leadership reviews emerging therapies continuously, and we only move forward when we’re confident a technology will genuinely benefit the children in our care.